首页> 外文期刊>The pharmaceutical journal >Boceprevir boosts hepatitis C treatment
【24h】

Boceprevir boosts hepatitis C treatment

机译:Boceprevir加强丙型肝炎治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Over 200,000 people in Britain are infected with the hepatitis C virus. Most are unaware — such is the nature of the infection. In most it remains undetected for years. But it can be ticking time-bomb capable of incapacitating its host's liver. "Seventy-five per cent of people infected with the hepatitis C virus are unable to clear the infection spontaneously and will require antiviral treatment," says Ashley Brown, consultant hepatologist at Imperial College Healthcare NHS Trust. "Up to a third of thos chronically infected may suffer premature death due to end-stage [liver] complications, although these may take 25 to 30 years to develop."
机译:在英国,有超过20万人感染了丙型肝炎病毒。大多数人不知道,这就是感染的本质。在大多数情况下,多年来仍未被发现。但是它可能是定时炸弹,它能够使宿主的肝脏失去功能。帝国学院医疗保健NHS Trust的顾问肝病学家Ashley Brown说:“感染丙型肝炎病毒的人中有55%无法自发清除感染,需要抗病毒治疗。” “由于晚期[肝脏]并发症,多达三分之一的慢性感染者可能会过早死亡,尽管这可能需要25至30年的时间才能发展。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号